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Bioinformatics Mining for Disease Causing Mutations using the 
Dog Genome as a Model for Human Disease 
Abstract 
Humans  and  dogs  share  many  common  diseases,  and  it  has  been  shown  that  the 
identification of mutations that cause disease in dogs can help unravel the genetic basis 
for a similar disease in humans. Mapping of traits and disease in dogs is not a new idea, 
but  the  sequencing  of  the  whole  dog  genome,  the  creation  of  a  dense  SNP  maps 
followed by the development of SNP arrays for high throughput genotyping has led to 
new facilitated mapping procedures. Each dog breed can be seen as a genetic isolate 
and certain breeds are often predisposed to specific diseases. Because of the genomic 
structure of the dog genome and the availability of new resources for disease mapping, 
the dog has been proposed to be especially advantageous for the mapping of complex 
disease that is difficult to map in human outbred populations.  
In  this  thesis,  the  aim  has  been  to  identify  disease-causing  mutations  for  three 
complex diseases in dogs with the presence of similar conditions in humans. Emphasis 
has  been  on  bioinformatics  analyses  of  genome-wide  SNP  and  large  re-sequencing 
data. 
In the dog breed Nova Scotia duck tolling retriever it is common with an immune-
mediated disease complex that resembles human systemic lupus erythematosus (SLE).  
In  paper  I  we  used  a  two-stage  genome-wide  association  mapping  method  and 
successfully  located  several  susceptibility  loci  in  dogs  for  this  disease  complex.  In 
paper II we identified a mutation that had been under selection in the Shar-Pei breed, 
causing both a breed-defining wrinkled skin phenotype and an autoinflammatory fever 
disease. Because the locus had been under selection we used an alternative mapping 
approach,  called  homozygosity  mapping  to  identify  the  locus,  followed  by  re-
sequencing using next generation sequencing technologies.  In paper III we report the 
development of a web-based tool that facilitates analyses and extraction of essential 
information from the large amount of data produced by next generation sequencing 
projects.  In  paper  IV  we  used  across-breed  genome-wide  association  mapping  to 
identify risk factors for glioma, a type of malignant brain tumor fatal to both human 
and dogs. For the three diseases excellent candidate genes have been identified, and 
continued research might has the potential to lead to better treatment options and thus 
benefit both dogs and humans. 
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1  Introduction 
 
1.1  Using the dog as a model for human disease 
 
The domestic dog (Canis lupus familiaris) is an excellent model species for the 
study of disease genetics. Humans share many common diseases with their 
canine friends, e.g. cancer, autoimmune diseases, epilepsy and heart disease. 
Disease manifestations are often similar in dogs and humans and most of our 
genes are orthologous (Karlsson & Lindblad-Toh, 2008). There are more than 
400 dog breeds (Wilcox & Walkowicz, 1995), all with differing behavioral and 
morphological characteristics. Most dog breeds were created during the past 
two  centuries  by  strong  artificial  selection  leading  to  relatively  inbred 
populations with sometimes unintended consequences concerning the health 
(Lindblad-Toh  et  al.,  2005).  There  are  often  high  incidences  of  specific 
diseases in certain breeds, explained by the random amplification of risk alleles 
during population bottlenecks or accidental enrichment because of hitchhiking 
of  mutations  near  selected  traits  or  pleiotropic  effects  of  selected  variants 
(Karlsson & Lindblad-Toh, 2008; Patterson et al., 1988).  
Complex  diseases  are  more  difficult  to  map  than  monogenic  classical 
Mendelian recessive or dominant traits. In general for a complex disease the 
phenotype is caused by the interaction of several genes, the environment and 
stochastic factors. (Lander & Schork, 1994). The recent breed-creation and low 
genomic  diversity  within  dog  breeds  implicates  that  increased  risk  is 
attributable  to  only  a  few  disease  alleles  of  strong  effect,  making  disease 
mapping potentially easier in dogs compared to human, especially for complex 
disease (Ostrander & Kruglyak, 2000).  
The diseases that were chosen for study in this thesis concordantly have 
similarities  with  human  disorders,  all  of  them  showing  a  complex  pattern. 
Firstly,  in  the  breed  Nova  Scotia  duck  tolling  retriever  it  is  common  with 
immune-mediated diseases including a disease-complex that resembles human   12 
systemic lupus erythematosus (SLE). Secondly, many dogs from the Shar-Pei 
breed suffer from a hereditary periodic fever syndrome that has similarities 
with  several  human  auto-inflammatory  syndromes.  Thirdly,  Brachycephalic 
(short-nosed) dog breeds such as Boxer, Bulldog and Boston terrier have an 
increased incidence of glioma, a type of brain tumors that are devastating to 
both dogs and humans. 
Identification  of  causative  loci  in  dogs  has  the  potential  to  increase 
knowledge about genes and pathways relevant to human disease, which might 
has the potential to lead to better diagnostics and improved treatment options 
for both species.  
1.2  Shaping the genome structure of the domestic dog 
Historical events have shaped the genome of the pure bred dog in a way that 
makes it excellent for genetic disease mapping. The genome structure of an 
individual  breed  bears  evidence  of  two  widely  spaced  major  population 
bottlenecks. The first bottleneck occurred at domestication and the second at 
breed-creation  with  subsequent  inbreeding  and  the  enrichment  of  inherited 
breed-specific  diseases  (Parker  et  al.,  2009;  Drogemuller  et  al.,  2008; 
Lindblad-Toh et al., 2005; Ostrander & Wayne, 2005).  
There is evidence that the dog is derived from gray wolves only and no 
other wild canids (Lindblad-Toh et al., 2005; Savolainen et al., 2002; Vila et 
al., 1997).  It is believed that domestication began more than 15,000 years ago, 
since there is ample archeological evidence of domesticated dogs from that 
time. Selection for desirable traits e.g. ability to hunt, guard, and herd, and for 
morphological traits like size and shape likely have prehistoric roots (Larson et 
al.,  2012).  There  are  several  examples  of  geographically  distributed  dog 
populations  sharing  identical  mutations  for  phenotypes  causing  for  instance 
hairlessness in Chinese and Mexican breeds (Drogemuller et al., 2008) and the 
ridge on the back of sub-Saharan African and Thai breeds (Salmon Hillbertz et 
al.,  2007).    At  least  19  breeds  share  the  same  mutation  causing  short  legs 
(Parker et al., 2009). These mutations are not likely to have arisen multiple 
times but imply that there has been a significant mixture of genetic material 
before the gene-pools were closed during the creation of the currently existing 
breeds (Larson et al., 2012).  
A few founder dogs have typically been used in the creation of each breed. 
Usually a breed standard has been agreed upon that further reduces diversity, 
encouraging  breeding  of  individuals  that  are  fairly  similar  in  type.  This 
breeding procedure has resulted in the loss of genetic diversity within a breed 
and a greater variation across breeds (Ostrander & Wayne, 2005).  
The two major bottlenecks, domestication and breed-creation, have resulted 
in long haplotype blocks, i.e. stretches with no recombination, within modern 
dog breeds (500 kb to 1Mb) and thus extensive linkage disequilibrium (LD), 
while short LD and short haplotype blocks (≈10 kb) are revealed as remnants 
from the ancestral dog population by comparison across breeds (Lindblad-Toh   13 
et al., 2005). It should be noted though that there are considerable differences 
in extent of LD between breeds due to differences in breed popularity and local 
population bottlenecks. Compared to humans, LD in dogs is 20-50 times more 
extensive  (Lindblad-Toh  et  al.,  2005;  Ostrander  &  Wayne,  2005;  Sutter  & 
Ostrander, 2004).  
Figure 1 illustrates how diversity is reduced during breed-creation. Long 
haplotype blocks are the results of the small number of meiosis that have taken 
place  since  breed  creation.  Note  that  since  some  shorter  haplotype  blocks 
residing within the longer blocks are shared by all haplotypes within a breed, 
they are in fact not visible, as long as they are not compared to breeds carrying 
other variants. 
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Figure 1.  Reduction of diversity during breed-creation. 
a)  Small  colored  blocks  represent  ancestral  haplotype  blocks  combined  in 
diverse ways in the dog population before breed-creation. b) At breed-creation, 
the diversity of haplotypes is reduced, and only a portion of the variation in the 
common  dog  gene  pool  is  brought  to  the  created  isolated  population.  c) 
Colored  boxes  surrounding  the  ancient  shorter  blocks  illustrate  longer 
haplotype blocks in the modern breed where no recombination has yet taken 
place. 
a)  Haplotypes+in++
domes0cated+dogs++
before+breed++
crea0on.+
b)+A+few+founder+animals+
with+a+selec0on+of+haplotypes+
from+the+larger+dog+popula0on.++
++
c)+A+modern+breed+with++
long+haplotype+blocks+
with+a++few+diﬀerent++
haplotypes,+and+short+
blocks+residing+within+
each+haplotype+as+
remnants+from+the++
ancestral+dog+popula0on+  15 
1.3  Resources that facilitate trait mapping in dogs 
Trait mapping in dogs has been facilitated by recent development of several 
new  resources.  A  high-quality  draft  sequence  of  a  female  Boxer  dog  was 
published  in  2005.  The  genome  was  covered  ≈  7.5  times  by  redundant 
sequence data, and the assembly included ≈99% of the euchromatic genome 
(Lindblad-Toh et al., 2005). The dog genome contains ≈ 2.4 x 10
9 base pairs 
and  is  divided  into  38  autosomal  chromosomes  and  the  X  and  Y  sex 
chromosomes. To be able to extract the full potential of the dog genome a 
dense SNP map is needed that can be used to explore the genetic variation 
within and among dog breeds. Hence the same authors produced a catalogue of  
>  2.5  million  SNPs  in  three  complementary  ways;  (1)  by  identifying 
heterozygous SNPs in the sequenced Boxer, (2) comparing the genome of the 
Boxer with the partial sequence of a standard Poodle (Kirkness et al., 2003) 
and  (3)  the  generation  of  random  reads  from  nine  additional  breeds,  four 
wolves and one coyote (Lindblad-Toh et al., 2005). 
Several  SNP  genotyping  arrays  have  been  developed  to  facilitate  high-
throughput  mapping.  These  are  the  26578  (27K)  and  the  49663  (50K) 
Affymetrix  SNP  arrays,  and  a  22,362  SNP  Illumina  array  (Karlsson  & 
Lindblad-Toh,  2008).  The  latest  contribution  is  the  173,622  canine  HD 
Illumina SNP array with a mean spacing of 13 kb (Vaysse et al., 2011). 
In addition to knowledge about the dog genome, another very important 
aspect  is  that  the  dog  has  been  intensely  studied  in  medical  practice. 
Furthermore, detailed family history and pathology data are often available 
(Hedhammar et al., 2011; Patterson, 2000). 
1.4  Genetic mapping of traits and diseases 
Genetic  mapping  has  the  goal  to  find  allelic  variants  that  are  causative  of 
certain  traits  or  that  increase  the  risk  of  certain  diseases.  The  underlying 
assumption is thus that the mutation occurred in a common ancestor to the 
individuals that share the phenotype in question, and that the mutation has been 
segregating through the generations. Alleles that are inherited from a common 
ancestor are said to be identical-by-descent (IBD). Figure 2 illustrates how a 
disease-causing mutation for a recessive disease is transmitted in a hypothetical 
pedigree, and is more likely to occur in two copies because of inbreeding.  
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Figure 2. Pedigree with an inherited recessive mutation. 
The  figure  illustrates  how  a  mutation  is  located  within  the  “short  yellow 
haplotype”, and how the mutation causes a change in phenotype when present 
in two copies. 
 
To  find  a  shared  mutation  that  is  IBD  is  a  fundamental  goal  for  disease 
mapping  and  applies  also  to  dominant  and  complex  modes  of  inheritance. 
Mapping can however be less straightforward than the illustration suggests, for 
reasons like incomplete penetrance, environmental and stochastic factors, and 
involvement  of  several  genes  such  as  different  modifiers  in  the  genetic 
background that complicates the picture. 
 
1.4.1  Linkage mapping 
A type of genetic mapping approach that was not used in this thesis but is 
worth mentioning is linkage mapping. Linkage mapping has frequently been 
used  in  the  past  and  has  clearly  been  the  method  of  choice  for  simple 
Unaﬀected)male)
Unaﬀected)female)
Aﬀected)male)
Aﬀected)female)  17 
Mendelian traits. The method is based on proposing a model for inheritance 
which requires a pedigree and a test for correlated transmission of trait/disease 
and  allele  within  a  pedigree  thus  using  individuals  with  known  relatedness 
(Lander & Schork, 1994).  Linkage studies do not need a control group and do 
not suffer from problems with heterogeneity and population stratification, as 
can be the case for genome-wide association studies (GWAS). A drawback is 
that  identified  regions  are  often  large  (>5  Mb),  and  test  statistics  used  are 
complicated (Ott et al., 2011).  
Trait mapping in dogs began in the 1990s using large multigenerational 
pedigrees and many trait loci have been identified. For reviews see (Karlsson 
& Lindblad-Toh, 2008; Sutter & Ostrander, 2004). 
In some cases the knowledge gained in dogs has opened doors for a wider 
understanding  of  similar  disease  conditions  in  humans.  Copper  toxicosis  in 
Bedlington terrier is one such example. It has been shown that a mutation in 
the MURR1 gene impairs the biliary excretion of copper in Bedlington terriers 
(van De Sluis et al., 2002). Wilson disease is a similar condition in humans 
resulting in toxic copper accumulation. An investigation of the MURR1 gene in 
humans  with  Wilson  disease  suggested  that  variants  in  this  gene  were 
associated  with  an  early  onset  of  disease  (Stuehler  et  al.,  2004).  Another 
example  is  narcolepsy,  for  which  an  autosomal  recessive  mutation  in  the 
hypocretin  2  receptor  gene  was  identified  in  a  canine  model.  The  results 
revealed a family of genes that were shown to encode major sleep-modulating 
neurotransmitters, enabling new treatments for narcoleptic human patients (Lin 
et al., 1999). 
 
1.4.2  Genome-wide association mapping 
Over the past few years, linkage mapping has lost its predominance in favor of 
genome-wide association mapping (GWAM). It is easier to collect case-control 
samples than family collections and the method makes it possible to map not 
only  Mendelian  traits,  but  also  common  risk  factors  for  complex  diseases. 
GWAM is based on tests of several markers for being in linkage disequilibrium 
with a trait or disease. True association and linkage disequilibrium (LD) arises 
either when a marker allele actually is the cause of disease, or if the marker 
allele  is  located  close  enough  to  the  causative  mutation.  The  mutation  is 
considered to be segregating from a common ancestor and show correlation 
with a marker if linkage has not yet been eroded by recombination (Lander & 
Schork,  1994).  In  practice,  allele  frequencies  for  affected  and  unaffected 
individuals from a population are compared using several markers and if one 
allele is significantly more frequent in cases than controls, then that allele is 
consequently associated with the trait.  
LD is dependent on population history and it may be advantageous to use 
isolated populations for mapping where LD is extensive, which require fewer 
markers  (Lander  &  Schork,  1994).  Isolated  populations  are  also  more 
homogenous, which can be of advantage especially for complex traits. Genetic   18 
heterogeneity  implies  that  a  risk  haplotype  co-segregates  with  a  disease  in 
some  families  but  not  others  (Lander  &  Schork,  1994).  In  outbred  human 
populations,  GWAS  have  difficulties  in  detecting  rare  variants  due  to 
heterogeneity (Ott et al., 2011). Another potential pitfall of association studies 
is the presence of stratification in the population, i.e. subgroups with differing 
allele  frequencies  that  might  cause  false  positive  association.  Cases  and 
controls should therefore, if possible, be matched to be as similar as possible 
except for the trait under investigation.  
Dog breeds have all the advantages of isolated populations for GWAM, as 
each breed can be seen as a genetic isolate. In the case where traits or disease 
are shared between several breeds the genetic structure of the dog genome 
makes  it  possible  to  efficiently  perform  the  mapping  using  a  two-stage 
strategy. It is likely that most disease-causing mutations arose prior to breed-
creation since there has been little time for novel mutations to accumulate since 
breed-creation (Karlsson & Lindblad-Toh, 2008). The first stage is performed 
within  a  single  breed  where  it  is  sufficient  to  use  a  sparse  set  of  markers 
(≈15,000) to identify an associated region of ≈1Mb. Simulations have shown 
that a recessive trait can be mapped with as few as 20 cases and 20 control 
(Lindblad-Toh et al., 2005) while a risk factor that multiplies risk with a factor 
5 for a complex disease has been simulated to be detected in 97% of data sets, 
using 100 cases and 100 controls and a set of 15,000 markers (Lindblad-Toh et 
al., 2005). In the second fine-mapping stage a denser set of SNPs and more 
breeds are included with the potential to narrow the region(s) to a few hundred 
kilobases  (Karlsson  &  Lindblad-Toh,  2008).    Proof  of  principle,  has  been 
shown by the mapping of two monogenic traits: white spotting in Boxer and 
other breeds as well as the hair ridge in Rhodesian ridgebacks using the 27,000 
SNP array and only 10 cases and 10 controls (Karlsson et al., 2007; Salmon 
Hillbertz et al., 2007). 
In certain situations extensive inbreeding can have negative consequences 
in  the  form  of  large  homozygous  regions  that  are  essentially  invisible  to 
association  mapping,  since  this  method  relies  on  allelic  segregation  of 
surrounding markers (Karlsson & Lindblad-Toh, 2008). When a trait is fixed 
within  a  breed  and  shared  by  several  breeds  an  alternative  approach  is  to 
perform across-breed GWAS. In these studies some individuals from several 
different  breeds  with  or  without  the  trait  in  question  are  compared.  Allele 
frequencies  differ  extensively  between  breeds,  making  the  risk  of  false 
positives higher than for studies performed within a single breed. With many 
different  breeds  included  in  the  study,  the  chance  is  higher  that  only  trait-
related  alleles  will  differ  consistently  (Karlsson  &  Lindblad-Toh,  2008). 
Across-breed mapping is most likely to be successful for mapping traits that 
have been under selection. In general, LD decays much faster between breeds, 
but for traits that have been under selection, the causative variant is likely 
located in a fixed long haplotype. Thus, LD is likely increased in the region 
under selection, given that affected breeds share a common founder ancestor 
for the trait in question (Vaysse et al., 2011).    19 
 
1.4.3  Homozygosity mapping 
Homozygosity mapping is a method that has been applied to find an allele 
causing  a  rare  disease  with  a  recessive  mode  of  inheritance.  The  region 
surrounding the disease allele is thus homozygous in affected individuals and 
the  method  relies  on  detecting  long  stretches  of  homozygosity  (Ott  et  al., 
2011). Since regions need to be long to be identified, this method is best suited 
for recent mutations that occur in families or in isolated populations. In the 
case of a recent mutation, homozygosity mapping is an option also in dogs. A 
success story is exemplified by the use of only five cases and 15 controls of the 
dog breed Old English Sheepdog that identified a mutation in the CCDC39 
gene as being responsible for a chronic airway inflammation with similarities 
to the human disease primary ciliary dyskinesia (PCD). Loss of function in the 
orthologous human gene was thereafter found in a substantial fraction of PCD 
patients  (Merveille  et  al.,  2011;  Ott  et  al.,  2011).    Strong  selection  for  a 
desirable trait can lead to homozygous (fixed) regions in all dogs within a 
breed. Such regions could also be possible to find with homozygosity mapping 
by screening the genome for large regions of homozygosity. The thick heavily 
wrinkled skin of Shar-Pei dogs is a selected trait that is unique to that breed. 
Sometimes  a  specific  fixed  trait  can  be  shared  among  several  breeds 
exemplified by chondrodysplasia (short legs) or brachycephaly (short nose). In 
the case of a shared mutation, it is possible to search for shared regions of 
homozygosity across such breeds. In those cases it could also be possible to 
perform across-breed association mapping as explained above. 
1.5  Next generation sequencing  
In the 1970s it became possible to clone and sequence deoxyribonucleic acid 
(DNA),  and  thereby  tie  genetic  linkage  to  the  underlying  DNA  sequence 
(Altshuler et al., 2008). For about three decades the primary choice for DNA 
sequencing  was  methods  requiring  electrophoretic  separations  of  DNA 
fragments.  It  was  the  development  of  high-resolution  methods  that  could 
separate  DNA  fragments  differing  in  size  by  just  one  base  that  made 
sequencing possible in the first place. For reviews see (Shendure & Ji, 2008; 
Shendure et al., 2004). Automation, parallelization, and refinements of Sanger 
sequencing  was  the  road  to  increased  cost-effectiveness  (Shendure  et  al., 
2004).  The goal to sequence the entire human genome was set already in 1985 
and motivated a cost reduction from US$ 10 per finished base to 10 bases per 
US$ 1 (Shendure et al., 2004). In 2001, two draft sequences of the human 
genome were published (Lander et al., 2001; Venter et al., 2001). In the wake 
of the human genome project several academic and commercial efforts were   20 
initiated with the aim to develop new ultra low cost sequencing technologies 
(Shendure et al., 2004). 
Over  the  past  seven  years  these  new  technologies  have  been  evolving 
rapidly,  and  massively  parallel  DNA  sequencing  platforms  are  now  widely 
available.    These  technologies  produce  relatively  short  reads  compared  to 
Sanger  sequencing.  The  utility  of  short  reads  became  stronger  and  more 
valuable with the availability of whole genome assemblies for human and other 
species. Those assemblies provided reference genome sequences from various 
different species against which short reads could be mapped, thereby providing 
information about genetic variation (Shendure & Ji, 2008). The term “second-
generation”  sequencing  was  proposed  by  (Shendure  &  Ji,  2008)  used  for 
implementations  of  parallelized  cyclic-array  sequencing  (e.g.  as  in  the 
commercial products: 454 Genome Sequencer, Illumina Genome Analyzer and 
the  SOLiD  platform).  Electrophoretic  separation  is  no  longer  needed,  but 
sequencing  is  performed  by  synthesis  in  iterative  cycles  of  enzymatic 
manipulation  and  image  base  data  collection.  Millions  of  PCR  colonies  of 
DNA fragments are immobilized to an array and are simultaneously sequenced 
in  parallel.  Now  “third  generation”  technologies  are  emerging  that  promise 
even  higher  throughput,  longer  read  lengths,  smaller  amounts  of  starting 
materials, higher consensus accuracy and even lower costs. For a review see 
(Schadt et al., 2010). 
Next generation sequencing (NGS) can be applied for a variety of reasons 
and it has the potential to dramatically accelerate biological and biomedical 
research (Schadt et al., 2010; Shendure & Ji, 2008).  
Genome-wide mapping studies in dogs where the mutation is shared by 
several breeds could identify candidate regions less than 100 kb, but candidate 
regions might be up to 2 Mb long for mutations that are specific to a single 
breed as discussed above (Karlsson & Lindblad-Toh, 2008). Re-sequencing of 
the entire region in several cases and controls would have been too costly prior 
to development of NGS technologies, but now provide the potential to identify 
the causative mutation.  In this thesis the Illumina NGS technology was used 
for targeted discovery of sequence variation in genomic regions associated to 
specific  traits  or  disease  (Paper  II  and  IV).  In  paper  III  we  assessed  the 
challenge  of  extracting  the  most  essential  information  from  the  very  large 
amount of data that is produced by next generation sequencing. 
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2  Aims of the thesis 
 
The overall aim of this thesis has been to mine the dog genome for genetic risk 
factors underlying canine genetic diseases, using bioinformatics methods. 
 
The specific aims were to: 
 
I.  Perform a genome-wide association study in the dog breed Nova Scotia 
duck tolling retriever to identify susceptibility loci for an immune-mediated 
disease  complex  with  similarities  to  human  systemic  lupus  erythematosus 
(SLE). 
 
II.  Map the locus for the characteristic wrinkled skin phenotype of the Shar-
Pei  breed,  and  to  map  the  breed-specific  Familial  Shar-Pei  Fever  (FSF),  a 
disease with similarities to several human autoinflammatory syndromes. 
 
III.  Develop an easy to use web-based tool for analyses of data from NGS 
projects,  in  order  to  facilitate  the  identification  of  causative  mutations  in 
targeted case-control re-sequencing projects.  
 
IV.  Identify the loci predisposing to an increased risk of gliomas (primary 
brain  tumors)  in  brachycephalic  (short-nosed)  dog  breeds,  and  place  it  in 
context of pathways for gliomagenesis relevant for human disease. 
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3  Genome-wide association mapping 
identifies several loci for an SLE-related 
disease in Nova Scotia duck tolling 
retrievers (Paper I) 
 
 
 
3.1  Background 
 
The incidence of autoimmune disease is overrepresented in the breed Nova 
Scotia duck tolling retriever (NSDTR). In particular, two types of immune-
mediated phenotypes are diagnosed more frequently in NSDTR compared with 
other  breeds.  These  are  immune-mediated  rheumatic  disease  (IMRD)  and 
steroid-responsive  meningitis-arteritis  (SRMA)  (Hansson-Hamlin  & 
Lilliehook, 2009; Anfinsen et al., 2008; Redman, 2002). A primary question in 
this project was to determine whether these represent two separate disorders, or 
if they share common genetic risk factors. The IMRD disease complex shares 
many  similar  clinical  features  with  human  systemic  lupus  erythematosus 
(SLE).  IMRD-affected  dogs  frequently  display  antinuclear  autoantibodies 
(ANA) (70%) and arthritis (100%). Other symptoms sometimes seen in both 
dogs  and  humans  include  fever  and  affection  of  skin,  liver  and  kidneys 
(Hansson-Hamlin & Lilliehook, 2009;  Koskenmies  et  al.,  2008;  Tan  et  al., 
1982).  Dogs diagnosed with SRMA usually have a typical acute course of 
disease with severe neck pain, stiffness and fever. In most cases, treatment with 
corticosteroids gives a good response (Anfinsen et al., 2008). 
Most  autoimmune  diseases  in  humans  are  the  result  of  a  complex 
inheritance  involving  several  genes,  stochastic  and  environmental  factors 
(Mariani, 2004). Similarly, pedigree analysis has indicated that the SLE-related 
diseases seen in NSDTRs involve polygenic inheritance.  The NSDTR breed   24 
has gone through a severe bottleneck, when a very small population survived 
two devastating outbreaks of canine distemper virus in 1908 and 1912 (Strang 
& MacMillan, 1996). 
In this paper we performed a Genome-Wide Association Study (GWAS) in 
NSDTR to locate candidate loci for this immune-mediated disease complex. 
Simulations have shown that for a complex trait, risk alleles that increase risk 
with a factor of 5 can be detected (in 97% of cases) using only ≈ 15,000 SNPs 
and  ≈100  cases  and  ≈100  controls  (Lindblad-Toh  et  al.,  2005).  Given  the 
recent population bottleneck and the high prevalence of disease in this breed, 
we expected to find a few strong risk factors.  
3.2  Methods and Results 
To perform genome-wide association mapping we used the Illumina canine 
SNP array with 22,000 markers. We used 81 cases (37 diagnosed with IMRD 
whereof 22 were ANA-positive and 44 diagnosed with SRMA) and 57 controls 
to identify five candidate loci located on CFA 3, 8, 11, 24 and 32. Analyses 
were performed for all cases together and for ANA-positive IMRD and SRMA 
cases separately (Figure 3). 
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Figure 3. (a) All cases analyzed together showed one strongly associated peak 
on CFA 32. (b) Associated regions were located on four chromosomes for 
ANA-positive dogs (CFA 3, 8, 11 and 24). c) One region on CFA 32 was 
significantly associated with SRMA. (Figure modified from paper I) 
 
The  software  tool  PLINK  (Purcell  et  al.,  2007)  was  used  to  perform  all 
statistical tests including association calculations and to adjust for population 
stratification and multiple testing.  The dogs used in the analyses were from 
Finland and Sweden and multidimensional scaling plots showed the presence 
of  some  population  stratification.  Identity-by-state  (IBS)  clustering  was 
therefore used to separate the samples into two groups. The Cochran-Mantel-
Haenszel (CMH) association statistics was then used to test for SNP-disease 
association conditional on the clustering. This method was used to avoid false 
positives due to subpopulations with differing allele frequencies, as well as to 
increase the power to detect true positives. The initial p-values were in the 
range  10
-5-10
-6.  In  a  second  step,  we  used  permutation  testing  (i.e.  label-
swapping of phenotypes) conditional on the clustering into two groups, thus 
both controlling for stratification and correcting for multiple testing. Corrected 
p-values  (Pgenome)  based  on  100,000  permutations,  reached  genome-wide 
significance (cut-off 0.05) for three loci, located on chromosome 8 (Pgenome 
≈0.02) and chromosome 24 (Pgenome ≈ 0.04) for ANA-positive dogs and on 
chromosome 32 (Pgenome ≈0.04) for dogs diagnosed with SRMA (Figure 3). 
All five loci were included in the proceeding fine-mapping. According to 
recommended state of the art, the whole genome mapping within one breed 
should be followed by fine-mapping in multiple breeds in order to identify   27 
shorter  across-breed  shared  haplotypes  (Karlsson  &  Lindblad-Toh,  2008).  
Unfortunately, since these SLE-like diseases are rare in other breeds, we did 
not have sufficient number of samples to be able to narrow down the regions 
using this method.  Nevertheless, fine-mapping also has the purpose to validate 
associated regions by adding additional cases and controls. SNPs were selected 
with a density of ≈ 1 SNP/10 kb in associated regions. Additional NSDTRs 
were included adding up to a total of 324 dogs (82 with IMRD, of which 32 
showed  ANA-positivity,  78  with  SRMA  and  173  controls;  nine  dogs  were 
classified  as  having  both  IMRD  and  SRMA).  Three  loci  (CFA  3,  11,  24) 
associated with ANA-positivity were strongly validated, with p-values in the 
range 10
-11-10
-13. The other two loci (CFA 8 and 32) were validated, but with 
weaker p-values of 10
-5 and 10
-8 in the fine-mapping stage. In the fine-mapping 
stage, a region of 1.6 Mb on CFA 32 was found to be the one most associated 
with SRMA, but also associated with ANA-positivity and consequently with 
all cases together. 
3.3  Discussion and future prospects 
In  conclusion,  five  loci  were  identified  as  associated  with  the  SLE-related 
disease  complex  in  NSDTRs  using  a  two-stage  mapping  strategy.  The 
associated regions contain several genes making it difficult to determine which 
are causative even though several of the genes are excellent candidates based 
on their biological function. Strikingly, four of the candidate genes (PPP3CA, 
HOMER2, DAPP1, and PTPN3) from three of the associated regions are all 
involved  in  regulation  of  the  nuclear  factor  of  activated  T  cells  (NF-AT) 
pathway.  It  is  well  established  that  the  NF-AT  transcription  factors  are 
involved in T-cell activation as well as the generation of peripheral tolerance 
against self-antigens (Serfling et al., 2006). Activation of calcineurin (encoded 
by PPP3CA), a well-known target for immunosuppressive drugs, results in the 
activation  of  the  NF-AT  pathway  (Clipstone  &  Crabtree,  1992).    Both 
calcineurin and NF-AT, have been reported to be differentially expressed in 
human  patients  with  SLE  compared  to  healthy  individuals  (Kyttaris  et  al., 
2007; Guerini, 1997). For more details about the candidate genes in associated 
regions, see paper I. 
As expected, it seems like a few loci, each with a strong effect to influence 
development of this immune-mediated disease complex are present in this dog 
breed, and that a combination of these genetic risk factors might be sufficient 
to predispose to disease. Since strong risk factors that are rare escape GWAS in 
humans,  we  suggest  that  studies  in  dog  can  be  a  valuable  complement  in 
identifying  genes  and  pathways  that  are  involved  in  complex  disease 
development and thus benefit both species. Hybrid capture followed by next 
generation sequencing was planned as the next step, to investigate associated 
regions in more detail and to be able to identify causative variants.  
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4  Homozygosity mapping identifies a locus 
under selection for the characteristic 
skin phenotype in Shar-Pei dogs (Paper 
II)  
 
4.1  Background 
 
The dog breed Shar-Pei has a breed-defining wrinkled skin phenotype that has 
been strongly selected for. The skin is thickened and folded and the muzzle is 
heavily  padded.  An  ancestral  type  of  Shar-Pei  with  less  accentuated  skin 
condition exists and is referred to as the “traditional” type Shar-Pei, while the 
type that has been selected for the skin phenotype is called the “meatmouth” 
type. It is known that the major component of the thickened skin in Shar-Pei 
dogs is hyaluronic acid (HA) and that meatmouth Shar-Peis also have two- to 
five-fold higher serum-levels of HA (Zanna et al., 2008). A similar condition 
has  been  described  in  humans  (Ramsden  et  al.,  2000)  and  termed 
hyaluronanosis. 
Apart from the skin condition, an autoinflammatory disease named Familial 
Shar-Pei Fever (FSF) is very common among meatmouth Shar-Peis. In 1992, 
as  many  as  23%  of  US  individuals  within  the  breed  were  estimated  to  be 
affected (Rivas et al., 1992). The disease clinically resembles some hereditary 
periodic  fever  syndromes  seen  in  humans,  such  as  Familial  Mediterranean 
Fever  (FMF).  The  condition  in  both  human  and  dog  is  characterized  by 
recurrent fever of unknown origin and local inflammation, usually affecting 
major joints. As a complication of recurrent or chronic inflammation, human 
patients as well as Shar-Pei dogs are at risk of developing reactive systemic 
AA amyloidosis and subsequent kidney or liver failure (Stojanov & Kastner, 
2005; Rivas et al., 1992). (AA amyloidosis is a form of amyloidosis associated 
with serum amyloid A protein (SAA) (Lachmann et al., 2007).)   30 
 
In  an  effort  to  identify  the  genetic  risk  factor/s  for  this  disease  we  first 
performed a GWAS using 18 cases and 18 controls, but without obtaining any 
significant results. (Data not shown in paper.) Dog breeds offer the power of 
genetically isolated populations for association mapping, but in cases when 
homozygosity  is  extensive,  large  genomic  regions  will  escape  detection  in 
association  mapping.  Hence  we  assumed  that  the  selection  for  the  skin 
phenotype, might have concealed the region responsible for the fever, and that 
finding the locus for the skin phenotype might also lead us to the mutation 
causing  the  fever  syndrome.  It  was  also  possible  that  the  study  was 
underpowered, and in parallel more samples were collected. 
4.2  Methods and results 
We screened the genome of the Shar-Pei for signs of selective sweeps, by 
searching for long stretches of homozygosity or a reduction in heterozygosity. 
We  investigated  the  Shar-Pei  genome  separately  by  searching  for  shared 
homozygosity in 50 Shar-Pei dogs, and also compared it to 230 control dogs 
from 24 other breeds.  We used a sliding window approach to investigate the 
ratio  of  heterozygosity  compared  to  other  breeds  in  every  window  of  10 
consecutive  SNPs,  using  50.000  SNPs  evenly  distributed  throughout  the 
genome (Affymetrix 50 K canine SNP array). The strongest signal of reduced 
heterozygosity was localized to a region of ≈3,7 Mb on CFA 13 (CanFam 2.0 
chr13:23,4879,92-27,227,623).  The  ratio  of  heterozygosity  in  Shar-Pei  dogs 
was 10-fold more reduced compared to the average ratio found in dogs from 
the control breeds (Fig 4 A) and nearly complete homozygosity was observed 
in Shar-Peis near the HA synthase 2 (HAS2) gene (Fig 4 C). HA is synthesized 
by three different HA synthases, (HAS1, HAS2, HAS3) with HAS2 being the 
rate limiting enzyme (Weigel et al., 1997).  Given the strong signal of selection 
and  knowing  that  the  skin  condition  is  due  to  excess  deposits  of  HA,  this 
emerged as an obvious candidate region for the mutation causing the wrinkled 
skin. 
In parallel, more dogs had been collected to perform a GWAS for the fever 
syndrome, and importantly the classification of phenotypes were more strictly 
defined than previously. In total 22 cases and 17 controls were compared and 
now reached genome-wide significance (best SNP Praw = 2.3 x 10
-6, Pgenome 
≈0.01  based  on  100.000  permutations)(Fig  4  B).  A  set  of  17,227  SNPs 
common to both the 27K and 50K array, were used in the analysis since all 
individuals  were  not  run  on  the  same  type  of  array.  The  software  package 
PLINK (Purcell et al., 2007) was used for association analysis. As can be seen 
in Fig 4C the most associated SNPs (blue line) were located on CFA 13 close 
to the region under selection. Since association cannot be detected where there 
is no variation, and thus goes down where homozygosity (red line) goes up, it 
is hard to determine the most likely location for a causative mutation.   31 
 
 
Figure 4.  Signs of a selective sweep and association to FSF 
a) The largest reduction in heterozygosity in Shar-Peis (n=50) compared to 24 
other  breeds  (n=230)  was  observed  on  chromosome  13.  The  relative 
heterozygosity was calculated sliding through 50,000 genome-wide SNPs with 
a window size of 10 consecutive SNPs. (b) A case-control study for Familial 
Shar-Pei Fever (FSF) showed the strongest association on CFA 13 (best SNP 
Praw  =  2.13  x  10
-6,  Pgenome  ≈0.01  based  on  100.000  permutations).  (c) 
Association with FSF co-localized with signals of selection on CFA 13. SNPs 
associated with FSF (blue line) were interspersed with signals of selection (red 
line). (Figure modified from paper II) 
 
To  search  for  the  mutation  causing  the  wrinkled  skin  phenotype 
(hyaluronanosis)  we  targeted  the  candidate  region  using  a  custom-designed 
sequence  capture  array  from  Roche  NimbleGen.  The  target  capture  was 
followed  by  re-sequencing  of  a  1.5  Mb  large  region  (CanFam  2.0 
chr13:22,937,592 24,414,650). This region was considered the most likely for 
having  been  under  selection,  and  included  the  candidate  HAS2  gene.  The 
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region  also  included  a  non-coding  RNA,  HAS2  antisense,  that  has  been 
proposed to act as a negative regulator of HAS2 (Chao & Spicer, 2005). Seven 
dogs were re-sequenced, two meatmouth Shar-Peis with high HA serum levels, 
two traditional type Shar-Peis and three dogs from other control breeds. The 
obtained  sequence  reads  were  mapped  to  the  Boxer  reference  genome 
sequence, and ≈1500 SNPs and ≈670 indels were identified in each dog. Nine 
variants (eight SNPs and one indel) were both unique to the two sequenced 
meatmouth Shar-Peis and were located within conserved elements. Additional 
genotyping of these variants in several Shar-Peis and dogs from other breeds 
showed that they were not specific to Shar-Peis and subsequently excluded as 
being causative for the phenotype. Comparisons of the coverage in the target 
region revealed two overlapping duplications in Shar-Pei dogs. Copy number 
analyses  were  performed  in  several  dogs  for  the  two  duplications,  and 
confirmed  that  the  duplications  were  unique  to  Shar-Peis.  The  larger 
duplication  with  a  size  of  16,1  kb  was  unique  to  meatmouth  Shar-Peis 
(CanFam 2.0 Chr13: 23,746,089–23,762,189) while a smaller duplication of 
14,3  kb  seemed  to  have  its  origin  in  the  traditional  Shar-Pei  (CanFam  2.0 
Chr13:23,743,906–23,758,214). 
Further it was discovered that there was a significant correlation between 
meatmouth copy number and the Familial Shar-Pei Fever (FSF) (p=<0.0001, 
Mann Whitney test). The fever syndrome affected most dogs with more than 
six copies, whereas dogs with less than four copies were not. 
In a limited study, using dermal fibroblasts from six meatmouth Shar-Peis, 
correlation between duplication copy number and RNA expression of HAS2 
and the HAS2 antisense gene (HAS2as) was examined. Both genes showed a 
strong correlation between increased expression and increasing copy number. 
 
4.3  Discussion and future prospects 
 
In  this  study  we  used  homozygosity  mapping  to  identify  a  region  under 
selection  in  Shar-Peis.  We  used  this  approach  because  we  searched  for  a 
homozygous region shared by all individuals in the breed, created by strong 
artificial  selection.  Homozygosity  mapping  can  also  be  used  to  identify 
homozygous  regions  present  only  within  cases  for  a  recessive  trait.  The 
mapping procedure is principally the same, but the homozygous region arose 
for  a  different  reason.    Following  homozygosity  mapping,  next  generation 
sequencing  of  the  identified  target  region  was  performed.    Genome-wide 
association  mapping  for  FSF  suggested  that  the  region  containing  a 
susceptibility locus for the fever syndrome co-localize with the region under 
selection for the wrinkled skin phenotype. We identified a duplication of 16,1 
kb unique to meatmouth Shar-Peis located 350 kb upstream of HAS2. Based on 
our findings we postulated that this duplication is the causative mutation for 
both hyaluronanosis and Shar-Pei fever because of the observed correlation   33 
between the number of copies and susceptibility to FSF. We suggested that one 
or  more  regulatory  elements  in  the  duplication  influence  HAS2  mRNA 
expression,  leading  to  the  higher  levels  of  HA  observed  in  dogs  from  this 
breed. We proposed that the duplication found in traditional type Shar-Pei dogs 
was  the  first  duplication  event  making  this  region  unstable,  facilitating  the 
second meatmouth duplication to occur by unequal crossing over.  
HA has a high turnover, and is degraded into polymers of decreasing size. 
These  hyaluronan  fragments  have  wide-ranging  and  sometimes  opposing 
biological functions. Large polymers are space filling and immunosuppressive, 
while smaller fragments seem to act as “danger signals” and are inflammatory 
and immune-stimulatory (Stern et al., 2006).  
The  functional  consequences  of  excessive  HA  in  Shar-Peis  need  to  be 
investigated further, but given the function of fragmented HA it is expected 
that the strong selection for the hyaluronanosis phenotype is contributing to 
induction of recurrent episodes of fever and inflammation. Approximately 60% 
of human patients with similar fever diseases are currently unexplained and we 
therefore  suggest  that  the  possible  involvement  of  HA  regulators  could  be 
relevant to investigate in more depth also in human patients. 
Finally, this study illustrates how a copy number variation can affect the 
phenotype and how strong artificial selection for a desired trait may have a 
pleiotropic  effect,  with  negative  impact  on  the  health  of  our  companion 
animals. 
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5  SEQscoring: a tool to facilitate the 
analysis of data from next generation 
sequencing projects (Paper III) 
 
5.1  Background 
 
The goal of a GWAS is to locate a region that is associated with a trait or 
disease.  Subsequent fine-mapping with a denser set of genetic markers can 
then  reduce  the  size  of  the  associated  region.  Finally,  re-sequencing  of  the 
associated region is required to identify candidate mutation/s that needs to be 
functionally validated as being the causative mutation. Before the development 
of next generation sequencing (NGS) technologies, mutation detection by re-
sequencing was a tedious and expensive task. For large regions, re-sequencing 
efforts have for that reason typically been limited to protein coding genes. An 
identified mutation in a coding exon will be the easiest to interpret, and several 
disease causing mutations inherited in a Mendelian fashion has been identified 
in coding exons (Altshuler et al., 2008). Yet, many regions outside genes have 
important regulatory effects, for example, with respect to the location, timing, 
and amount of gene expression. Regulatory mutations are likely to be common 
particularly in complex diseases (Epstein, 2009). NGS allows rapid, affordable, 
and  comprehensive  re-sequencing,  and  thus  provide  the  opportunity  to 
investigate  larger  genomic  regions  for  identification  of  disease-causing 
mutations.  Causation  of  identified  candidate  mutations  needs  then  to  be 
confirmed by functional assays. 
In the two projects previously described in this thesis (Papers I and II) the 
subsequent  step  after  genomic  mapping  was  to  perform  re-sequencing.  The 
genomic susceptibility region in Shar-Peis for harboring the causative mutation   36 
selected for the skin phenotype was ≈1.5 Mb in size. Conveniently we were in 
phase with the recent introduction of NGS technologies on the market and it 
was thus feasible to re-sequence the entire region in a few cases and controls.  
After re-sequencing we were faced with the large amount of data produced, 
and stood in front of the next challenge of how to extract the most essential 
information and how to be able to identify the most likely causative mutation. 
During the course of  data  analyses,  the  idea  was  born  to  make  use  of  our 
lessons learnt, and develop a web-based tool that would be easy to use. 
It has been shown that elements that are conserved across species, and thus 
are  under  purifying  selection,  are  more  likely  to  have  biological  function 
(Birney et al., 2007; Drake et al., 2006; Woolfe et al., 2005; Margulies et al., 
2003).  Consequently,  the  web-based  software  tool  SEQscoring  that  we 
developed, utilizes the power of comparative genomics and was developed to 
score  variants  according  to  the  degree  of  conservation  at  their  location. 
SEQscoring also assesses the pattern of variants between cases and controls in 
order to identify a set of the most likely causative mutations for a trait. 
 
5.2  Methods and Results 
 
Several programs have been developed to map millions of reads to a reference 
sequence and to call variants, e.g. BWA (Li & Durbin, 2009), SAMtools (Li et 
al., 2009) and MAQ (Li et al., 2008). SEQscoring supports several file formats 
as input data. In figure 5 an overview of SEQscoring functionalities is shown. 
In the “Scoring module”, variants are scored according to the degree of 
conservation at the genomic position. SEQscoring keeps a local database of 
species  alignments  from  some  different  sources  where  the  degree  of 
conservation has been assessed (e.g. 29 mammal constraint scores, 16 amniota 
vertebrates and human/mouse/rat/dog/ comparison (Lindblad-Toh et al., 2011; 
Paten  et  al.,  2008;  Siepel  et  al.,  2005).  The  conservation  score  source  is 
selected by the user and a file with all detected variants is uploaded to the 
website. All variants are accordingly checked and recorded with a score from 
the database, and the information is returned to the user. 
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Figure 5.  Overview of SEQscoring functionalities. 
Input to the program is submitted by the user in the form of lists of variants 
and/or information about coverage/position. Variants are scored according to 
evolutionary conservation at the genomic position for the variant. a) SNPs are 
color-coded (as explained in the text) and individual samples can be merged 
and displayed in the UCSC browser for visual inspection of shared haplotypes 
and presence of variants at conserved positions (red). b) The Case & Control 
module performs pairwise comparisons of all samples and helps the user to 
rank  the  variants  by  concordance  with  an  expected  pattern  for  a  causative 
variant. c) Coverage calculations are performed to find differences between 
cases and controls, with the goal to localize structural variants, like deletions or 
duplications. (Figure modified from paper III.) 
 
The “Merge & Show” module merges the results for all samples and facilitates 
interpretation by visualization.  Variants are displayed in the UCSC genome 
browser  for  easy  comparison  of  samples,  and  investigation  of  haplotype 
structure. The SNPs are color-coded in the following way: homozygous SNPs 
within or near (± 5bp) conserved elements are colored red; heterozygous SNPs 
within or near (±  5bp)  are  colored  pink;  non-conserved  homozygous  SNPs 
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equal to the reference are colored yellow; homozygous SNPs deviating from 
the reference are colored blue; heterozygous non-conserved SNPs are colored 
green. 
The “Case & Control” module helps the user to rank variants by differences 
between  cases  and  controls.  The  user  is  offered  three  options:  1)  to  rank 
variants according to an expected pattern between cases and controls by pair-
wise comparison of all samples; 2) to transform data for performing traditional 
association studies, 3) to compare genomic regions, by using a window of a 
specific size and, sliding through all consecutive variants.  
Using the first option, variants are selected as the most likely for being 
causative, based on whether they are located within a conserved element and 
whether  segregating  as  expected  for  a  phenotype-genotype  correlation.  The 
second option is useful if the number of samples is large enough for doing an 
association study. The third option, to compare genomic regions, is most useful 
for identifying selective sweeps or homozygous regions harboring a mutation 
for a recessive trait. 
The “Coverage module” aims to find structural variations, such as deletions 
or duplications (copy number variations). Coverage for different samples can 
vary, and therefore data is normalized, to obtain comparable figures. The ratio 
of average coverage between cases and controls in consecutive windows of 
user-specified size are calculated, and the results are visualized as graphs that 
can be displayed in the UCSC genome browser.  
In  the  paper  we  exemplify  the  use  of  SEQscoring  by  describing  the 
selection of a set of the most likely candidate mutations in the Shar-Pei project.  
We  had  re-sequenced  a  ≈1.5  Mb  target  region  using  Illumina  Genome 
Analyzer, and mapped the reads to the CanFam 2.0 (Lindblad-Toh et al., 2005) 
reference genome sequence using the software tool MAQ (Li et al., 2008). We 
analysed  two  “meatmouth”  Shar-Peis  with  an  excess  of  serum  HA  and 
compared them to three normal controls from other breeds.  ≈1500 SNPs/ per 
individual were detected. We scored the variants by conservation according to 
the UCSC PhastCons alignment of four species (Siepel et al., 2005) and used 
the “Merge and Show” module to merge the information for the individual 
samples. A total of 3430 SNPs were detected that differed compared to the 
reference, and out of these 84 were located within conserved elements. The 
“Case & Control” module allowed ranking of the SNPs and we found that only 
eight of the conserved SNPs had a pattern where the two Shar-Peis were alike 
and differed from the controls. Using the “Coverage module” coverage was 
checked  for  every  10
th  position  and  the  average  coverage  for  cases  was 
compared to the average coverage for controls for every consecutive window 
with a size of 1 kb. As can been seen in figure 6 there was one distinct peak of   39 
excessive coverage in the two Shar-Peis. The blue graph shows the log2 values 
of the ratios between cases and controls. In paper II we showed that Shar-Peis 
have a 16.1 kb duplication at the site of this peak. 
 
 
 
Figure 6.  Copy number detection by coverage comparison. 
An example of how the form is filled out in SEQscoring for doing coverage 
comparisons. The results are displayed below the form, with the blue graph 
showing the coverage ratio (log2) between cases and controls. The site of the 
peak was shown to harbor a copy number variation. 
 
5.3  Discussion and future prospects 
The  publicly  available  SEQscoring  tool  was  developed  to  facilitate  the 
interpretation of data from NGS-projects.  At the time we expected the user to 
re-sequence a limited set of samples (≈6-12) and our goal was to evaluate the   40 
vast amount of variants present and extract a set of the most likely causative 
mutations  for  a  trait  or  disease.  We  proposed  a  method  where  extracted 
variants  should  be  validated  by  genotyping  in  a  larger  cohort  of  cases  and 
controls. The program has been frequently used in our laboratory and by our 
collaborators. The methodology has been proven successful in several cases to 
narrow the possibilities and pinpoint highly likely susceptibility mutations. 
We focus on filtering out conserved variants, but we recommend our users 
to select also non-conserved variants for evaluation in a larger cohort, since 
functional elements sometimes show a low degree of sequence conservation. 
Development is moving towards even lower costs, giving the opportunity to 
pool  and  re-sequence  many  more  samples.  SEQscoring  also  offers  the 
opportunity to transform data to perform association studies (PLINK (Purcell 
et al., 2007) format), which may be more suitable in projects including large 
sample sets.  
Some limitations should be mentioned for targeted re-sequencing projects. 
It  will  not  be  possible  to  detect  larger  insertions  relative  to  the  reference 
genome sequence, since such sequences will not be included in the probes used 
to capture the target region. Since the read length is quite short (≈30-100 bp) it 
limits the size of repetitive regions that can be read through, which makes 
differences in size of microsatellites, presence of long interspersed nucleotide 
elements (LINEs) and short interspersed nucleotide elements (SINEs) etc. hard 
to detect. It appears that we are moving towards longer reads for many of the 
new technologies. Longer paired end reads and the use of de novo assembly 
into  longer  contigs  prior  to  mapping  might  help  overcome  some  of  these 
limitations. 
There are several functionalities that could be added to SEQscoring in the 
future. For instance, the user can currently only determine if a variant is located 
within a conserved variant. A lot more information could be useful for the user, 
as if the variant is located in a protein coding exon, if the mutation will cause a 
codon  change,  and  if  there  is  a  regulatory  element  at  the  site  with  known 
function.  SEQscoring  could  also  be  given  functions  to  evaluate  data  from 
whole genome RNA sequencing. Here it would be useful to extract information 
about  new  transcripts,  and  new  splice  variants,  as  well  as  differences  in 
expression of different transcripts in cases and controls. Protein interactions is 
another compelling feature to add, to get an integrated picture of how extracted 
candidates  fit  in  a  network,  and  thereby  get  a  broader  understanding  of 
pathways and genes involved for a certain condition. 
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6  Across-breed genome-wide association 
mapping identifies a glioma susceptibility 
locus 
 
6.1  Background 
 
Gliomas  are  primary  brain  tumours  derived  from  glial  cells,  and  the  most 
common form of malignant brain tumors in humans. Gliomas are classified 
according  to  different  grades  of  malignancy  and  patients  with  the  most 
malignant form, grade IV, has an approximate survival time of one year (Louis, 
2006).  Compared  to  humans,  dogs  have  a  similar  or  higher  incidence  of 
gliomas (Dobson et al., 2002; Hayes et al., 1975). It has been observed that 
brachycephalic (short-nosed) dog breeds have a considerable elevated risk of 
developing gliomas (Hayes et al., 1975). 
Brachycephaly is a trait that has been under strong selection. A short broad 
skull and a severely shortened muzzle characterize the phenotype. The breeds 
with the most elevated risk, Boxer, Boston terrier and Bulldog share a common 
ancestor, an “ancestral Bulldog” (Hayes et al., 1975). The “ancestral” Bulldog 
was bred for the sport “bull baiting” before it was forbidden in England 1835.  
According to historical records, the original Bulldog was crossed with Pugs at 
that time, leading to a more extreme brachycephalic phenotype that is seen in 
modern breeds (Voss, 1933).  
Brachycephalic breeds like Pugs and Pekingese do not seem to have an 
elevated  risk  (Hayes  et  al.,  1975),  making  us  hypothesize  that  glioma  risk 
factors are descending in the ancestral Bulldog line, and thus arose before the 
cross with the Pug.  Because of the strongly elevated risk in certain breeds with 
common  ancestry,  we  expect  them  to  carry  shared  genetic  risk  factors  for   42 
glioma. In humans, some rare inherited mutations have been identified. It has 
been agreed that there is a need to expand research in genetics and molecular 
epidemiology of brain tumors.  Even though rare inherited mutations account 
for few cases they are important for identifying pathways for gliomagenesis 
(Bondy  et  al.,  2008).  We  propose  that  mutations  identified  in  dogs  will 
likewise benefit both dogs and humans by the identification of genes involved 
in glioma pathways. 
In a previous study we performed across-breed genome-wide association 
mapping and identified a locus at CFA 1 with strong evidence of having been 
under selection for brachycephaly (Bannasch et al., 2010). In this study we 
performed an across-breed genome-wide study for glioma followed by targeted 
re-sequencing to search for mutations causing brachycephaly and/or glioma.  
6.2  Methods and Results 
We performed a GWAS for glioma using 39 cases and 142 controls from 25 
different pure bred and four mixed dog breeds. The latest developed Illumina 
array with 173,622 SNPs was used. The strongest association was found on 
CFA  26  (Fig  7).  We  noted  that  the  population  structure  caused  inflated  p-
values, and genomic control (GC) was therefore used to correct the chi-square 
test statistics. The software tool PLINK (Purcell et al., 2007) was used for the 
analysis.  
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Figure 7.  Across-breed GWAS for glioma. 
The strongest association for glioma appears on chromosome 26 
 
Five breeds among the cases are related to the “ancestral Bulldog”: Boxer, 
English Bulldog, French Bulldog, Boston terrier, and Staffordshire terrier. We 
investigated the possibility of a selective sweep common to those breeds and 
found a completely homozygous region with respect to SNP markers spanning 
≈  4Mb,  including  the  most  glioma-associated  region.    There  were  no 
comparable signs of selection in this region in Pugs that are brachycephalic but 
not related to the ancestral Bulldog. 
The next step was to go from SNP markers, to investigate the full sequence 
in order to identify candidate mutations causing brachycephaly and/or glioma. 
We performed targeted re-sequencing of in total 7 Mb from the previously 
identified brachycephaly locus on CFA 1 and the newly identified glioma locus 
on CFA 26. In total nine dogs were re-sequenced (two Boxers, one Pug, one 
English Bulldog, one French Bulldog, one Boston terrier, one Dachshund, one 
Welsh Corgi, and one Basset hound). Four of the dogs had been diagnosed 
with glioma.  
In total 20,998 SNPs were identified. We used SEQscoring (Truvé et al., 
2011) (Paper III) as previously described and found that out of these, 1,086 
SNPs  were  located  within  conserved  elements.  The  SNPs  were  ranked 
according to the expected pattern of segregation between cases and controls for 
causative variants. In addition, two structural variations were identified (one 
160 bp duplication, and one 2200 bp insertion). The structural variants and the 
top ranked SNPs from both conserved and non-conserved SNPs were selected 
for validation by genotyping. 
In total 100 candidate SNPs were successfully genotyped in 168 dogs. Since 
we were interested in both glioma and brachycephaly the data was divided in 
subgroups for the analyses. The two structural variants were less associated 
than the best SNPs. One SNP located on CFA 1 was very strongly associated 
with brachycephaly. We located strongly associated candidate SNPs for glioma   44 
on CFA 26. The best two SNPs were located in introns of excellent candidate 
genes  based  on  biological  function,  and  within  newly  discovered  intronic 
transcripts  with  unknown  function.  A  third  SNP  got  our  attention  since  it 
caused a non-synonymous codon change. 
6.3  Discussion and future prospects 
We have mapped a locus on CFA 26 associated with glioma and shown that 
this region has probably been under selection and is thus shared by all the high-
risk breeds. When emphasis was on finding a brachycephaly locus including 
brachycephalic  breeds  with  no  evidence  of  an  increased  glioma  risk,  the 
strongest  association  was  found  on  CFA  1.  The  history  of  breeds  and  our 
results, suggest that the locus on CFA 26 is descending in breeds related to an 
ancestral Bulldog, while the CFA 1 locus is inherited from an ancestor of the 
Pug. 
 
 
 
Figure 8. Suggested segregation of loci under selection.  
The  sweep  signal  on  CFA26  seems  to  have  originated  in  the  “ancestral 
Bulldog” while the brachycephaly association on CFA1 seem to have its origin 
in an ancestor to the Pug. (Painting of “ancestral Bulldog” from 1790.) 
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The SNP most associated to brachycephaly as validated here was located in an 
intron of the gene SMOC2. This gene was already suggested as a candidate in 
our previous paper (Bannasch et al., 2010), but this present research either 
brought us much closer to or actually hit a causative variant, since the best 
validated SNP was much more associated than the best SNP from the GWAS. 
The position of the SNP is not conserved, and its function is thus not obvious. 
The SMOC2 gene product is a matricellular protein that is expressed in the 
craniofacial region of developing mouse embryos and therefore SMOC2 is a 
strong candidate gene (Bloch-Zupan et al., 2011). It is possible that the site of 
the  SNP  harbors  a  transcription-factor  binding  site  that  regulates  SMOC2 
transcription  but  further  research  is  required  to  functionally  evaluate  the 
mutation.  
For glioma we identified three genes as very likely candidates for being 
involved in disease development. We think that follow up research in humans 
should not be limited to the SNPs found in dogs, but all differences that could 
be found between normal and tumor cells for those genes could be of interest 
in the unraveling of cause for disease development. GWAS studies in humans 
have shown that a single locus can harbor several different risk variants. Even 
if individual SNPs might have a small effect, drug targeting of the encoded 
protein could have a much greater effect (Altshuler et al., 2008). The most 
important result from mapping studies in both humans and dogs is the gained 
knowledge about disease mechanism and disease pathways. In the manuscript 
(Paper IV) we report a literature research assessing how our candidates interact 
with genes with an established role in pathways for gliomagenesis. To our 
knowledge, none of our candidate genes has been proposed to be involved in 
the development of glioma before, but recent research in other forms of cancer 
(as  described  in  the  manuscript)  make  us  propose  that  we  have  identified 
putative drug-targets for glioma. 
For  our  glioma  candidate  genes  there  are  several  different  known 
transcripts.  In  addition,  recent  RNA  sequencing  in  dogs  (unpublished  data) 
suggests the existence of small intronic transcripts and more splice variants 
than what has previously been detected. Intriguingly for one of the candidate 
genes other research has shown that some splice variants are more commonly 
expressed in cancer cells including glioma (Davare et al., 2011; Frigo et al., 
2011;  Hsu  et  al.,  2001).  Given  this  we  propose  that  it  is  important  to 
investigate  the  expression  pattern  of  all  transcripts  of  these  genes  in  more 
detail. At present, we are investigating the presence of some of the transcripts 
in glioma and normal cells for both dogs and humans. A more comprehensive 
analysis comparing whole genome RNA sequence data for glioma and normal 
cells, in both dogs and humans would probably be the best way to continue the   46 
research.  For one of the candidates other research has shown that inhibiting its 
expression blocks migration of cancer cells (See paper IV). Of great interest is 
to test if this would hold true also for glioma cells. Preferable such inhibition 
studies  could  distinguish  between  different  splice  variants  and  intronic 
transcripts. Finally because of the similarity between disease development in 
dogs and humans the dog also offers an excellent model to test new treatment 
options. 
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7  Conclusions 
 
The results described in this thesis confirm that the dog is an excellent model 
for  disease  mapping.  In  addition  it  can  be  concluded  that  the  dog  with 
advantage can be used also for mapping of complex disease. Since it is much 
more problematic to map complex disease in human populations the dog model 
will likely continue be a helpful complement in revealing pathways for the 
development of human disease.  
Three different complex diseases were mapped in dogs and we also showed 
examples of the use of three different mapping procedures. Conclusions were 
drawn and the results and future prospects were  discussed for each project 
separately in this thesis.  However, the main conclusions for each project are as 
follows: 
 
o  Five	 ﾠloci	 ﾠhave	 ﾠbeen	 ﾠidentified	 ﾠthat	 ﾠare	 ﾠstrongly	 ﾠassociated	 ﾠwith	 ﾠ
an	 ﾠ SLE-ﾭ‐related	 ﾠ disease	 ﾠ in	 ﾠ Nova	 ﾠ Scotia	 ﾠ duck	 ﾠ tolling	 ﾠ retriever.	 ﾠ
Strong	 ﾠ candidate	 ﾠ genes	 ﾠ involved	 ﾠ in	 ﾠ regulation	 ﾠ of	 ﾠ T-ﾭ‐cell	 ﾠ
activation	 ﾠ was	 ﾠ found	 ﾠ in	 ﾠ these	 ﾠ regions.	 ﾠ In	 ﾠ this	 ﾠ work	 ﾠ GWAS	 ﾠ
within	 ﾠone	 ﾠbreed	 ﾠwas	 ﾠperformed	 ﾠfollowed	 ﾠby	 ﾠfine-ﾭ‐mapping	 ﾠto	 ﾠ
validate	 ﾠ the	 ﾠ regions	 ﾠ of	 ﾠ association.	 ﾠ Mapping	 ﾠ within	 ﾠ breed	 ﾠ is	 ﾠ
preferable	 ﾠperformed	 ﾠwhen	 ﾠpossible	 ﾠfor	 ﾠbest	 ﾠtaking	 ﾠadvantage	 ﾠ
of	 ﾠthe	 ﾠgenomic	 ﾠstructure	 ﾠof	 ﾠthe	 ﾠdog.	 ﾠ
	 ﾠ
o  A	 ﾠduplication	 ﾠof	 ﾠ16,1	 ﾠkb	 ﾠunique	 ﾠto	 ﾠmeatmouth	 ﾠShar-ﾭ‐Peis	 ﾠwas	 ﾠ
identified	 ﾠ350	 ﾠkb	 ﾠupstream	 ﾠof	 ﾠthe	 ﾠHAS2	 ﾠgene.	 ﾠWe	 ﾠconcluded	 ﾠ
that	 ﾠthis	 ﾠduplication	 ﾠis	 ﾠlikely	 ﾠthe	 ﾠcausative	 ﾠmutation	 ﾠfor	 ﾠboth	 ﾠ
the	 ﾠheavily	 ﾠwrinkled	 ﾠand	 ﾠthickened	 ﾠskin	 ﾠphenotype	 ﾠin	 ﾠShar-ﾭ‐Pei	 ﾠ
dogs,	 ﾠand	 ﾠfor	 ﾠthe	 ﾠfever	 ﾠsyndrome	 ﾠcommon	 ﾠin	 ﾠthis	 ﾠbreed.	 ﾠIn	 ﾠthis	 ﾠ
study	 ﾠwe	 ﾠshowed	 ﾠthat	 ﾠhomozygosity	 ﾠmapping	 ﾠcan	 ﾠbe	 ﾠused	 ﾠto	 ﾠ
identify	 ﾠa	 ﾠmutation	 ﾠthat	 ﾠhas	 ﾠbeen	 ﾠstrongly	 ﾠselected	 ﾠfor	 ﾠand	 ﾠis	 ﾠ
fixed	 ﾠwithin	 ﾠa	 ﾠbreed.	 ﾠ  48 
	 ﾠ
o  A	 ﾠweb-ﾭ‐based	 ﾠsoftware	 ﾠtool	 ﾠSEQscoring	 ﾠwas	 ﾠdeveloped.	 ﾠThe	 ﾠuse	 ﾠ
of	 ﾠtargeted	 ﾠNGS	 ﾠfollowing	 ﾠthe	 ﾠmapping	 ﾠof	 ﾠan	 ﾠassociated	 ﾠlocus	 ﾠ
offers	 ﾠboth	 ﾠopportunities	 ﾠand	 ﾠchallenges.	 ﾠSEQscoring	 ﾠhas	 ﾠbeen	 ﾠ
shown	 ﾠto	 ﾠbe	 ﾠuseful	 ﾠfor	 ﾠextracting	 ﾠand	 ﾠidentifying	 ﾠa	 ﾠset	 ﾠof	 ﾠthe	 ﾠ
most	 ﾠ likely	 ﾠ causative	 ﾠ mutations	 ﾠ from	 ﾠ the	 ﾠ vast	 ﾠ amount	 ﾠ of	 ﾠ
variants	 ﾠ identified	 ﾠ in	 ﾠ NGS	 ﾠ projects.	 ﾠ The	 ﾠ extracted	 ﾠ set	 ﾠ of	 ﾠ
mutations	 ﾠ should	 ﾠ then	 ﾠ be	 ﾠ validated	 ﾠ in	 ﾠ a	 ﾠ larger	 ﾠ cohort	 ﾠ of	 ﾠ
samples,	 ﾠfollowed	 ﾠby	 ﾠfunctional	 ﾠstudies.	 ﾠ	 ﾠ
 
o  A	 ﾠ locus	 ﾠ associated	 ﾠ with	 ﾠ glioma	 ﾠ was	 ﾠ mapped	 ﾠ on	 ﾠ CFA	 ﾠ 26.	 ﾠ
Mutations	 ﾠwere	 ﾠidentified	 ﾠin	 ﾠgenes	 ﾠthat	 ﾠclosely	 ﾠinteract	 ﾠwith	 ﾠ
genes	 ﾠknown	 ﾠto	 ﾠbe	 ﾠinvolved	 ﾠin	 ﾠhuman	 ﾠglioma	 ﾠpathways.	 ﾠIn	 ﾠthis	 ﾠ
study	 ﾠ we	 ﾠ performed	 ﾠ across-ﾭ‐breed	 ﾠ GWAS.	 ﾠ Across-ﾭ‐breed	 ﾠ
mapping	 ﾠshould	 ﾠbe	 ﾠperformed	 ﾠwith	 ﾠcare,	 ﾠbut	 ﾠwill	 ﾠwork	 ﾠbest	 ﾠfor	 ﾠ
traits	 ﾠor	 ﾠdiseases	 ﾠin	 ﾠbreeds	 ﾠsharing	 ﾠa	 ﾠrecent	 ﾠcommon	 ﾠancestor.	 ﾠ	 ﾠ
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8  Populärvetenskaplig sammanfattning 
8.1  Hunden kan användas för att hitta sjukdomsframkallande 
mutationer 
Hundar  och  människor  drabbas  av  samma  sjukdomar  som  t.ex.  cancer, 
epilepsi, autoimmuna sjukdomar och hjärt- och kärlsjukdomar.  Våra gener är 
också mycket lika hundens gener, vilket gör att om vi kan hitta orsaken till en 
ärftlig sjukdom i hundens arvsmassa, så kan denna kunskap hjälpa oss att förstå 
också hur sjukdomen uppkommer och utvecklas hos oss människor. Det finns 
idag  mer  än  400  hundraser  och  de  flesta har skapats genom avel under de 
senaste  200  åren.  De  flesta  hundar  inom  en  ras  är  som  bekant  ganska  lika 
varandra och ofta är det bara ett fåtal individer som från början varit med och 
bildat varje ras. Renrasiga hundar har stamtavlor som visar deras släktträd och 
ingen avel över rasgränser får förekomma.  På grund av denna strikta avel är 
variationen i arvsmassan mellan olika hundar inom en hundras mycket lägre än 
variationen mellan olika människors arvsmassa. Vissa sjukdomar är också ofta 
mycket vanligare inom vissa hundraser. Att det har blivit så beror antagligen 
både på slumpen och på att vissa sjukdomsframkallande mutationer av misstag 
har ”liftat” med en egenskap som selekterats för inom en ras. Detta kan ske då 
en mutation som orsakar sjukdom ligger nära något som man vill selektera för i 
arvsmassan. En och samma mutation kan också i vissa fall ha flera effekter 
både önskade och oönskade.  
För att hitta var i arvsmassan mutationerna ligger görs genetisk kartläggning 
med hjälp av s.k. genetiska markörer d.v.s. positioner i arvsmassan som ofta 
varierar  mellan  individer.  Flera  hundar  som  har  diagnosticerats  med  en 
sjukdom jämförs gentemot friska kontroller. Om ett område identifieras där de 
sjuka hundarna har mer lika markörer och skiljer sig från kontrollerna, så ligger 
troligtvis den sjukdomsframkallande mutationen i närheten d.v.s. detta område 
i  arvsmassan  är  associerat  med  sjukdomen.  För  att  hitta  själva  mutationen   50 
måste  varje  position  i  arvsmassan  inom  detta  område  analyseras.    Många 
sjukdomar  kan  bero  på  flera  orsaker.  Det  kan  vara  flera  olika  gener  som 
samverkar, eller defekter i olika gener som ger samma symptom. Miljön och 
slumpmässiga faktorer kan också vara avgörande för huruvida man drabbas av 
sjukdom.  Sjukdomar  som  påverkas  av  flera  faktorer  kallas  för  komplexa 
sjukdomar. Det kan vara lättare att hitta orsaken till komplexa sjukdomar hos 
hund än hos människan på grund av att hundar från en och samma ras har 
mindre variation i sin arvsmassa samt att det inom en ras troligen bara finns ett 
fåtal ofta starka riskfaktorer om sjukdomen är överrepresenterad inom rasen. 
Arvsmassan som också kallas för genomet består av långa dubbel-strängar av 
deoxiribonukleinsyra (DNA). DNA kan utvinnas från ett vanligt blodprov. 
I den här avhandlingen har tre olika sjukdomar hos hund med förekomst av 
liknande komplexa sjukdomar hos människa studerats. Syftet har varit att hitta 
regionen i genomet som är associerad med sjukdom och därefter identifiera 
mutationen  som  orsakar  sjukdom.  Hos  hundrasen  Nova  Scotia  duck  tolling 
retriever är det vanligare än hos andra hundraser med en autoimmun sjukdom 
som  liknar  sjukdomen  SLE  (systemisk  lupus  erythematosus)  hos  människa.  
Hundrasen  Shar-Pei  får  ofta  en  sjukdom  som  ger  feber  och  svullna  leder. 
Denna  sjukdom  kallas  Shar-Pei  feber  och  liknar  så  kallade 
autoinflammatoriska  sjukdomar  som  också  drabbar  människor.    Både 
människor och hundar kan drabbas av hjärntumörer. Den vanligaste maligna 
formen  hos  människa  kallas  gliom.  Vissa  raser  med  kort  nos  som  boxer, 
Boston terrier och bulldog har en mycket högre risk än andra raser att drabbas 
av gliom.  
 
 
 
 
8.2  En SLE-liknande sjukdom kartlagd hos Nova Scotia 
 duck tolling retriever 
I  avhandlingens  första  delarbete  beskrivs  hur  vi  sökt  efter  genetiska 
riskfaktorer  för  ett  SLE-liknande  sjukdomskomplex  hos  Nova  Scotia  duck 
tolling retriever. Vi använde DNA från 81 sjuka hundar och 57 kontroller och 
analyserade dessa med 22000 SNP markörer i hundens DNA.  Vi identifierade 
5  områden  i  genomet  som  är  associerade  med  det  SLE-liknande 
sjukdomskomplexet. För att verifiera att vi hittat rätt område utfördes en så 
kallad fin-mappning där vi analyserade de identifierade områdena i mer detalj, 
genom att analysera fler markörer inom regionerna och genom att inkludera   51 
fler hundar i analysen.  Inom dessa områden finns flera gener. Några av de 
mest associerade generna har en känd biologisk funktion som tyder på att det är 
mycket  troligt  att  dessa  gener  är  inblandade  i  sjukdomens  uppkomst.  Vid 
autoimmuna sjukdomar attackerar kroppens egna immunförsvar olika vävnader 
i kroppen. En typ av celler i immunförsvaret som brukar vara inblandade är så 
kallade T-celler.  Flera av de gener som vi fann vara associerade är kända för 
att vara inblandade i samma process av händelser som leder till aktivering av 
T-celler.    Nästa  steg  är  att  identifiera  mutationerna,  och  att  undersöka  om 
motsvarande gener är involverade i sjukdomen SLE hos människor. 
 
8.3  Selektiv avel för rynkig hud hos hundrasen Shar-Pei kan 
medföra sjukdom 
I delarbete II beskrivs hur vi hittade mutationen som orsakar en febersjukdom 
hos Shar-Pei hundar.  Vi hittade till att börja med ingen association och antog 
därför att det möjligen var för lite variation i området för att denna metod 
skulle  fungera.  Shar-Pei  hundar  har  en  karakteristisk  skrynklig  hud-fenotyp 
som det har kraftigt selekterats för inom aveln. När det görs en sådan kraftig 
selektering medför det att, i området omkring den orsakande mutationen blir 
hundarna  inom  rasen  mer  lika  än  vad  de  är  i  andra  delar  av  genomet.  Vi 
prövade därför en annan kartläggningsmetod, som går ut på att hitta just sådana 
områden där individer är mer lika varandra. Vi hittade ett sådant område precis 
bredvid en gen som är involverad i syntes av hyaluronsyra. Det är känt att det 
finns mycket hyaluronsyra i huden hos Shar-Pei hundar och att detta troligen 
orsakar den tjocka veckade huden. Vi var därför övertygade om att vi hittat det 
område  som  selekterats  för  och  gjorde  ett  antagande  att  den  mutation  som 
orsakar febern fanns dold i detta område. Vi sekvenserade därför 1.5 miljoner 
baspar av DNA för att försöka hitta mutationen. Vi hittade ett område på 16.1 
tusen baspar som hade blivit duplicerat och alltså fanns i flera kopior. Vi kunde 
därefter visa att denna mutation säkerligen orsakar både den skrynkliga huden 
och medför risk för att utveckla febersjukdomen. Denna studie pekade också 
på att hyaluronsyra eller andra gener som samverkar med detta ämne i kroppen 
kan vara intressant att studera i mer detalj hos människa där det för de flesta 
fall av autoinflammatoriska sjukdomar inte finns någon känd orsak. 
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8.4  SEQscoring ett verktyg för att underlätta analys av stora 
mängder DNA sekvens 
I delarbete III beskriver vi ett datorverktyg som vi utvecklat för att underlätta 
analys av stora mängder DNA sekvens. Detta verktyg finns på en websida och 
är tillgängligt för alla som vill använda det. Som beskrivet ovan är första steget 
att hitta en region i genomet där en mutation för en sjukdom eller egenskap kan 
finnas. Nästa steg är att sekvensera detta område. På varje position i DNA 
sekvensen finns en av fyra så kallade nukleotider eller baser, adenin, cytosin, 
tymin och guanin. Dessa brukar skrivas med bokstäverna A, C, T och G. Den 
sekvens som ska analyseras kan vara flera miljoner baser lång. I en så lång 
sekvens kan många av positionerna variera mellan individer, och svårigheten är 
att veta vilka varianter som är mest troliga att orsaka sjukdom. Vissa DNA 
sekvenser är konserverade och alltså väldigt lika mellan arter.  Det är mest 
troligt att de konserverade områdena har en funktion, och mutationer i sådana 
områden av arvsmassan är alltså mest troliga att orsaka sjukdom eller andra 
förändringar.  Programmet som vi utvecklat kallas för SEQscoring och hjälper 
användaren genom att markera vilka varianter som är konserverade. Om flera 
individer sekvenserats, görs också jämförelser mellan fall och kontroller för att 
filtrera fram ett litet antal av de mest troliga varianterna. Dessa varianter kan 
därefter undersökas vidare hos fler individer, för att slutligen kunna avgöra 
vilken  eller  vilka  varianter  som  är  orsakande  eller  medför  ökad  risk  för 
sjukdom.  När  en  sådan  här  stor  sekvensering  utförs  erhålls  i  första  steget 
miljarder  av  korta  sekvenser  på  mellan  30-100  baser  för  varje  individ. 
Eftersom  hela  hundgenomet  har  sekvenserats  så  kan  dessa  korta  sekvenser 
passas  in  mot  denna  referens,  och  enstaka  positioner  som  varierar  kan 
identifieras. SEQscoring kan också användas för att kontrollera hur mycket 
täckning det finns för olika regioner, och därigenom kan ett område som har 
blivit duplicerat eller deleterats i genomet upptäckas. 
8.5  Kartläggning av ökad genetisk risk att drabbas av 
hjärntumör 
I artikel IV beskrivs hur vi hittat ett område i genomet som är associerat med 
risk att få en typ av hjärntumör som kallas gliom.  I denna studie användes 
173622 markörer jämt spridda över hela genomet. Vi jämförde 39 fall av gliom 
gentemot 142 friska kontroller. Både gliomfallen och de friska kontrollerna 
kom från flera olika hundraser.  När man utför en associationsstudie på detta 
sätt mellan raser är variationen mycket högre än inom en ras. Det är större risk 
att hitta falska positiva och det behövs fler markörer för att hitta rätt område. 
Vi hittade ett område som var mycket starkt associerat. Det är känt att vissa   53 
raser med kort nos har högre risk att utveckla gliom, och dessa raser har ett 
gemensamt ursprung från en typ av ”original bulldog”. De raser som har högst 
risk att utveckla gliom är engelsk bulldog, Boston terrier och boxer. Vi kunde 
konstatera att i det associerade området för gliom var dessa hög-risk- raser 
extremt lika.  Efter associations-studien gjorde vi en omfattande sekvensering 
och använde SEQscoring för att filtrera ut de mest troliga mutationerna.  De 
mutationer  vi  hittat  ligger  i  gener  som  tidigare  inte  indikerats  att  vara 
inblandade i utvecklandet av gliom. En litteraturstudie visar att de samverkar 
med gener som har en känd roll i gliomutveckling. Än mer positivt är att när 
genuttrycket av en av dessa kandidat-gener hindras i andra typer av cancer har 
mycket  goda  resultat  uppnåtts.  Detta  ger  hopp  om  att  även  tillväxt  och 
spridning  av  gliomtumörer  kan  hämmas  genom  att  inhibera  denna  gen.  Nu 
behövs funktionella studier av dessa kandidat-gener, och förhoppningsvis kan 
det på sikt leda fram till nya mediciner, där även hunden kan vara till hjälp för 
att testa fram nya behandlingsformer. 
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